CRANDELL KEITH
CIK 1219039
Transactions on file
22
Open-market buys
7
Win rate (buys)
60%
5 scored
Avg % since filing (buys)
-6.8%
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-10-19 | 2026-10-19 | CTY CITY THERAPEUTICS, INC. | 10% | Buy | 170,000 | $3.06M | +15.4% | open → |
| 2026-10-19 | 2026-10-19 | CTY CITY THERAPEUTICS, INC. | 10% | C | 2,027,006 | $0.00 | — | open → |
| 2026-10-19 | 2026-10-19 | CTY CITY THERAPEUTICS, INC. | 10% | C | 5,482,309 | $0.00 | — | open → |
| 2026-10-19 | 2026-10-19 | CTY CITY THERAPEUTICS, INC. | 10% | C | 3,294,900 | $0.00 | — | open → |
| 2026-07-06 | 2026-07-01 | BOLD Boundless Bio, Inc. | 10% | Sale | 16,000 | $39.8K | -5.2% | open → |
| 2026-07-06 | 2026-07-01 | BOLD Boundless Bio, Inc. | 10% | Exer. | 16,000 | $16.5K | +129.1% | open → |
| 2026-06-24 | 2026-06-22 | KARD Kardigan, Inc. | Director10% | Buy | 1,250,000 | $20.00M | -20.0% | open → |
| 2026-06-22 | 2026-06-17 | KARD Kardigan, Inc. | C | 13,792,035 | $0.00 | — | open → | |
| 2026-06-12 | 2026-06-10 | MASS 908 Devices Inc. | Exer. | 14,083 | $0.00 | — | open → | |
| 2025-02-03 | 2025-02-03 | MTSR Metsera, Inc. | 10% | C | 7,523,682 | — | — | open → |
| 2025-02-03 | 2025-02-03 | MTSR Metsera, Inc. | 10% | Buy | 1,432,224 | $25.78M | — | open → |
| 2025-02-03 | 2025-02-03 | MTSR Metsera, Inc. | 10% | Buy | 789,998 | $14.22M | — | open → |
| 2025-02-03 | 2025-02-03 | MTSR Metsera, Inc. | 10% | C | 16,006,949 | — | — | open → |
| 2025-02-07 | 2025-02-05 | TWST Twist Bioscience Corp | Director | Grant | 4,472 | $0.00 | — | open → |
| 2025-06-13 | 2025-06-11 | MASS 908 Devices Inc. | Director10% | Exer. | 11,364 | — | — | open → |
| 2026-05-04 | 2026-05-04 | SPTX Seaport Therapeutics, Inc. | Buy | 1,100,000 | $19.80M | +21.9% | open → | |
| 2026-05-04 | 2026-05-04 | SPTX Seaport Therapeutics, Inc. | C | 2,681,265 | $0.00 | — | open → | |
| 2026-05-04 | 2026-05-04 | SPTX Seaport Therapeutics, Inc. | C | 2,513,686 | $0.00 | — | open → | |
| 2025-11-14 | 2025-11-13 | MTSR Metsera, Inc. | Director10% | Disp. | 8,313,680 | $0.00 | — | open → |
| 2025-11-14 | 2025-11-13 | MTSR Metsera, Inc. | Director10% | Disp. | 18,503,128 | $0.00 | — | open → |
| 2025-10-29 | 2025-10-27 | NMRA Neumora Therapeutics, Inc. | 10% | Buy | 1,915,700 | $5.00M | -72.0% | open → |
| 2025-08-01 | 2025-08-01 | PRME Prime Medicine, Inc. | 10% | Buy | 3,030,300 | $10.00M | +20.9% | open → |
